Post-transplant lymphoproliferative disorders of oral cavity (Q37149602)

18 August 2017

1 reference

title

Post-transplant lymphoproliferative disorders of oral cavity (English)

1 reference

lymphoproliferative disorders

18 August 2017

main subject

1 reference

Junu Ojha

1

1 reference

18 August 2017

Nadim Islam

2

1 reference

18 August 2017

Donald M Cohen

3

1 reference

18 August 2017

David Marshal

4

1 reference

18 August 2017

Michael R Reavis

5

1 reference

18 August 2017

Indraneel Bhattacharyya

6

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

18 August 2017

published in

1 reference

18 August 2017

volume

105

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

589-596

1 reference

The diagnosis and treatment of posttransplant lymphoproliferative disorders

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

The post-transplant lymphoproliferative disorder-a literature review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Posttransplant T-cell lymphoma. Report of three cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Hodgkin's disease following solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Clinical characteristics of post-transplant lymphoproliferative disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Post-transplant lymphoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Posttransplant lymphoproliferative disorder in pediatric renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Identifying the patient at risk for post-transplant lymphoproliferative disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

Epstein-Barr virus-associated lymphoproliferative disease in oral cavity in a renal transplant recipient: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2007.11.028

10.1016/J.TRIPLEO.2007.11.028

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference